A study of a new sub-cutaneous formulation of Actemra/RoActemra in chldren with polyarticular-course juvenile idiopathic arthritis
A study of a new sub-cutaneous formulation of Actemra/RoActemra in children with polyarticular-course juvenile idiopathic arthritis
- Registry ID
- EUCTR2012-003486-18
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE1
- Sponsor
- F. Hoffmann-La Roche Ltd.
- Start date
- 2013-06-14
- Completion date
- 2016-05-19
- Last update
- 2026-08-16
Conditions
- Polyarticular-course juvenile idiopathic arthritis (pcJIA)
Summary
Primary Objective
- To characterize the pharmacokinetics of subcutaneous tocilizumab (SC TCZ) in patients with pcJIA.
Locations
- , , Spain
- , , Poland
- , , Germany
- , , UK
- , , Italy
View on source registry